Why is Pharmaids Pharma falling/rising?

As of 03-Sep, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 62.15, which reflects a decrease of 0.75 or 1.19%. The stock has underperformed its sector today by 2.43% and has shown a trend reversal after two consecutive days of gains. Although the stock is trading higher than its 5-day and 50-day moving averages, it remains below the 20-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 0.40%, and it has also seen a significant drop of 11.82% year-to-date, despite a strong performance of 52.70% over the past year. The company is facing operational losses and has a weak long-term fundamental strength, with a negative EBITDA and a high debt-to-EBITDA ratio, which contributes to its current price movement.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with the Sensex showing a slight decline of 0.27% over the same week. While Pharmaids has outperformed the BSE500 in the long term, the recent flat results and high debt levels indicate underlying financial challenges that may deter investor confidence. The company's ability to service its debt is low, and despite rising investor participation indicated by a significant increase in delivery volume, the overall sentiment remains cautious due to the company's operational struggles and negative growth trends.